Navigation Links
Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS*
Date:3/24/2009

ies throughout Europe and numerous distribution and partnership agreements around the globe.

To help it pursue its development in new markets, Stallergenes is supported by unique expertise and the responsiveness of its structure. In high-potential emerging markets such as Russia, Stallergenes adopts a tailored product offer strategy, working with partners closely involved in the field of respiratory allergy treatment.

In the last five years, five new subsidiaries have been opened in Europe and several partnership agreements have been signed.

About Stallergenes

Stallergenes is a European biopharmaceutical company dedicated to desensitization therapies for the prevention and treatment of allergy-related respiratory diseases, such as rhinoconjunctivitis and allergic asthma. A pioneer and leader in sublingual desensitization treatments, Stallergenes devotes 21% of its turnover, in gross terms, to Research and Development and is actively involved in the development of a new therapeutic class: sublingual desensitization tablets.

In 2008, Stallergenes had a turnover of 171 million euros and more than 500,000 patients were treated with Stallergenes desensitization products.

Stallergenes is listed on Euronext Paris (Compartment B and is part of the sample composing the SBF 120 index.

    ISIN code: FR0000065674
    Reuters code: GEN.PA
    Bloomberg code: GEN.FP
    Additional information is available athttp://www.stallergenes.com
    About Solvay Pharmaceuticals

Solvay Pharmaceuticals is a research driven group of companies that constitutes the global pharmaceutical business of the Solvay Group. These companies seek to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardiometabolic, influenza vaccines, gastroenterology and men's and women's healt
'/>"/>

SOURCE Stallergenes
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded
2. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
3. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
4. Stallergenes Inaugurates the Biggest Pharmaceutical Allergen Production Unit in the World
5. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
6. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
7. Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
8. STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure
9. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
10. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
11. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... , Aug. 18, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: ... proprietary technologies and products for advanced microarray diagnostics, today ... Friday, August 22 at 2:00 pm ET.  ... will provide a brief review of SQI,s recent commercialization ... a diagnostics industry veteran recently appointed to the Board ...
(Date:8/18/2014)... 18, 2014 Global HIV Infection Drug ... announced by Reportstack. The rate of HIV infection and the ... declining note at a positive rate across the globe. It ... million in 2005 to 1.5 in 2013, with the rates ... such drastic changes in the infection rates has been the ...
(Date:8/18/2014)... Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... technologies are used to develop, manufacture and sell ... chemical, biopharmaceutical and industrial enzyme industries, announced today ... Form 10 with the U.S. Securities and Exchange ... http://photos.prnewswire.com/prnh/20110621/CL06708LOGO The Form 10 ...
(Date:8/16/2014)... grant from the Walmart Foundation to build a robotic ... the manufacturing costs of goods, allowing those goods to ... built overseas. , The Walmart U.S. Manufacturing Innovation Grant ... awards to seven research and development institutions at the ... the collaboration between Walmart, the U.S. Conference of Mayors ...
Breaking Biology Technology:SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 2SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4Dyadic International Files Form 10 Registration Statement 2Dyadic International Files Form 10 Registration Statement 3Dyadic International Files Form 10 Registration Statement 4UT Arlington receives Walmart, Walmart Foundation innovation grant 2UT Arlington receives Walmart, Walmart Foundation innovation grant 3
... $40 Million ... , ... 18, 2010 -- DuPont announced plans to expand its cutting-edge plant genetics research to help ... in central Iowa with additional lab facilities and jobs focused on advanced plant genetics., , ...
... ... Voxel Tracker™ is first-of-its-kind , ... Pittsburgh, PA (Vocus) March 18, 2010 -- Celsense, Inc. ... The software, dubbed Voxel Tracker™, was designed to optimize the use of Celsense’ ...
... experimenters three years to believe, University of Michigan engineers ... twist ribbons of nanoparticles. The results are published ... Matter readily bends and twists light. That,s the mechanism ... the opposite interaction has rarely been observed, said Nicholas ...
Cached Biology Technology:DuPont to Expand Plant Genetics Research Facilities 2DuPont to Expand Plant Genetics Research Facilities 3Novel Imaging Software Released by Celsense Inc. 2Novel Imaging Software Released by Celsense Inc. 3Light twists rigid structures in unexpected nanotech finding 2Light twists rigid structures in unexpected nanotech finding 3
(Date:8/19/2014)... students in college biology and other science courses ... quantitative ways, and now they have a new ... the Life Sciences," published this month by Princeton ... Institute for Mathematical and Biological Synthesis (NIMBioS), teaches ... can be used to explore and explain biological ...
(Date:8/19/2014)... of UTSA researchers has been awarded a nearly $40,000 ... Training (NCPTT), an office of the National Park Service ... will fund a one-year study of the energy efficiency ... homes in hot, humid climates. , Radiant barriers are ... that reflect heat back, thereby reducing the amount of ...
(Date:8/19/2014)... a number of ways. They have an impressive ability ... After being struck by lightning, for example, a tree ... one major downside to life as a plant: They ... they live and therefore completely at the mercy of ... developed mechanisms that enable them to rapidly adapt their ...
Breaking Biology News(10 mins):New textbook introduces undergraduates to mathematics for the life sciences 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3How steroid hormones enable plants to grow 2
... Surgical treatment for mitral valve disease includes either ... a metal, mechanical valve or an animal tissue valve. ... require a major incision in the chest. Now, after ... Medical Center in Baltimore conclude that minimally invasive mitral ...
... species in the Basque Country, and alternative to Pinus ... and Alonsotegui (Muro, 1975) where the eucalyptus, amongst other ... plantations such as those of eucalyptus came about in ... pulp industry. Blights and diseases arose as one of ...
... 28th, 2009 New prenatal tests for Down syndrome are soon ... States, yet telling an expectant couple that their child will ... physicians are trained for, claims research published in the ... decades of surveys and interviews, offers several recommendations for how ...
Cached Biology News:Study details safe, effective, minimally invasive mitral valve repair 2Study details safe, effective, minimally invasive mitral valve repair 3Canker disease in eucalyptus in the Basque Country 2Canker disease in eucalyptus in the Basque Country 3Canker disease in eucalyptus in the Basque Country 4How to deliver the news? New advice for doctors diagnosing prenatal Down syndrome 2How to deliver the news? New advice for doctors diagnosing prenatal Down syndrome 3
Rabbit polyclonal to SpUlp2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SNNERQSLSSGSND, corresponding to amino acids 622-635 of Schizosaccharomyces pombe SpUlp2...
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
ANTI-HUMAN CYTOKINES, GROWTH FACTORS (polyclonal rabbit (or goat) antibodies) Human TARC - Biotin...
Biology Products: